McKinley Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

McKinley Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-178,552	Closed	-$1.46M	–	346
2017 Q4	$1.46M	Sell	178,552 -206,188	-54%	-$1.97M	0.07%	189
2017 Q3	$4.03M	Sell	384,740 -70,302	-15%	-$780K	0.16%	104
2017 Q2	$5.02M	Buy	455,042 +129,538	+40%	+$1.21M	0.19%	85
2017 Q1	$2.72M	Buy	325,504 +142	+0%	+$1K	0.1%	142
2016 Q4	$2.26M	Buy	325,362 +102,373	+46%	+$653K	0.09%	159
2016 Q3	$1.14M	Sell	222,989 -274,302	-55%	-$1.64M	0.04%	244
2016 Q2	$2.97M	Buy	+497,291	New	+$2.76M	0.14%	159

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

McKinley Capital Management's ENZ Position: Q1 2018 in Review

McKinley Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 178,552 shares — an estimated $1.46M sold.

McKinley Capital Management first reported a position in ENZ in Q2 2016 and held it in 7 quarters. The position peaked at $5.02M in Q2 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

McKinley Capital Management reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
McKinley Capital Management sold 178,552 Enzo Biochem, Inc. shares in Q1 2018, an estimated $1.46M.
McKinley Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2016 and held it in 7 quarters.
McKinley Capital Management's Enzo Biochem, Inc. position peaked at $5.02M in Q2 2017.
107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on McKinley Capital Management's 13F filing for Q1 2018, filed 4 May 2018.